Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Roche's Foundation Medicine wins FDA blessing for new cancer test

ZURICH (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumors and guide them to effective therapies.

Roche, which owns 58 percent of Foundation, is hoping to use the FoundationOne CDx assay to personalize cancer care, where treatment is better tailored to the specific molecular characteristics of each patient's disease.

(Reporting by John Miller)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.